Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jia-Yu Fu

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse]Yan-rong Liu, Yan Chang, Jia-yu Fu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis]Yan-Rong Liu, Shan-Shan Chen, Yan Chang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2004
[Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]Yan-rong Liu, Le-ping Zhang, Yan Chang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 28, 2006
[Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia]Ya-Zhe Wang, Yan Chang, Hong-Hu Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 11, 2005
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR]Ya-zhen Qin, Guo-rui Ruan, Yan-rong Liu, et al.
Zhonghua Yi Xue Za Zhi|January 13, 2006
[Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Nature Neuroscience|November 29, 2022
Distinct serotonergic pathways to the amygdala underlie separate behavioral features of anxietyXiao-Dan Yu, Yi Zhu, Qi-Xin Sun, et al.
CNS Neuroscience & Therapeutics|February 9, 2024
S-9-PAHSA's neuroprotective effect mediated by CAIII suppresses apoptosis and oxidative stress in a mouse model of type 2 diabetesJian-Tao Wang, Xin-Ru Wang, Jiao-Qi Ren, et al.
Nature Medicine|January 16, 2019
Cannabinoid CB<sub>1</sub> receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behaviorChen-Jie Shen, Di Zheng, Ke-Xin Li, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Comparison of the immunophenotype of patients with B lineage acute lymphoblastic leukemia at diagnosis and relapse]Yan-rong Liu, Yan Chang, Jia-yu Fu, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|November 14, 2006
[Leukemia-associated immunophenotypes in 415 childhood and adult patients with B lineage acute lymphoblastic leukemia by multiparametric flow cytometry analysis]Yan-Rong Liu, Shan-Shan Chen, Yan Chang, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2004
[Two Ph chromosome positive chronic myelogenous leukemia patients with rare bcr/abl fusion gene]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 1, 2006
[Clinical significance for minimal residual disease detection by 4 color flow cytometry in adult and childhood B lineage acute lymphoblastic leukemia]Yan-rong Liu, Le-ping Zhang, Yan Chang, et al.
Zhongguo Shi Yan Xue Ye Xue Za Zhi|June 28, 2006
[Application of CD123 in detection of minimal residual disease in acute promyelocytic leukemia]Ya-Zhe Wang, Yan Chang, Hong-Hu Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 11, 2005
[Monitoring bcr/abl mRNA levels in imatinib mesylate treated chronic myeloid leukemia patients by real-time quantitative RT-PCR]Ya-zhen Qin, Guo-rui Ruan, Yan-rong Liu, et al.
Zhonghua Yi Xue Za Zhi|January 13, 2006
[Analysis of ABL tyrosine kinase point mutations in imatinib treated chronic myelogenous leukemia patients]Ya-zhen Qin, Yan-rong Liu, Jin-lan Li, et al.
Nature Neuroscience|November 29, 2022
Distinct serotonergic pathways to the amygdala underlie separate behavioral features of anxietyXiao-Dan Yu, Yi Zhu, Qi-Xin Sun, et al.
CNS Neuroscience & Therapeutics|February 9, 2024
S-9-PAHSA's neuroprotective effect mediated by CAIII suppresses apoptosis and oxidative stress in a mouse model of type 2 diabetesJian-Tao Wang, Xin-Ru Wang, Jiao-Qi Ren, et al.
Nature Medicine|January 16, 2019
Cannabinoid CB<sub>1</sub> receptors in the amygdalar cholecystokinin glutamatergic afferents to nucleus accumbens modulate depressive-like behaviorChen-Jie Shen, Di Zheng, Ke-Xin Li, et al.
Pageof 5